Dr. Bunnapradist is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 UCLA Medical Plz Ste 565c
Los Angeles, CA 90095Phone+1 310-267-2555Fax+1 310-206-3607
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Nephrology, 1998 - 1999
- Tufts Medical CenterFellowship, Nephrology, 1996 - 1998
- Columbus HospitalResidency, Internal Medicine, 1993 - 1996
- Chulalongkorn University Faculty of MedicineClass of 1993
Certifications & Licensure
- CA State Medical License 1998 - 2026
- IL State Medical License 1995 - 1996
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Small Bowel Capsule Endoscopy Findings in Patients Receiving Cellcept® Start of enrollment: 2009 Apr 01
- Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation Start of enrollment: 2010 Nov 01
- Mechanisms of Belatacept Effect on Alloimmunity and Antiviral Response After Kidney Transplantation (BMS IM 103-309) Start of enrollment: 2013 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 24 citationsAcute Kidney Allograft Rejection Precipitated by Lenalidomide Treatment for Multiple MyelomaErik L. Lum, Edmund Huang, Suphamai Bunnapradist, Thu Pham, Gabriel M. Danovitch
American Journal of Kidney Diseases. 2017-05-01 - 333 citationsCell-Free DNA and Active Rejection in Kidney AllograftsRoy D. Bloom, Jonathan S. Bromberg, Emilio D. Poggio, Suphamai Bunnapradist, Anthony Langone
Journal of the American Society of Nephrology. 2017-07-01 - 76 citationsImmunosuppression of the elderly kidney transplant recipient.Gabriel M. Danovitch, Jagbir Gill, Suphamai Bunnapradist
Transplantation. 2007-08-15
Press Mentions
- Natera Announces New Prospera™ Data at the ATC 2021 Virtual Connect ConferenceJune 4th, 2021
- Natera Announces Data from the ProActive Study That Supports Prospera(TM) Kidney as an Early Indicator of Transplant RejectionJune 6th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: